GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » argenx SE (FRA:1AE) » Definitions » Cyclically Adjusted PB Ratio

argenx SE (FRA:1AE) Cyclically Adjusted PB Ratio : (As of May. 24, 2024)


View and export this data going back to 2018. Start your Free Trial

What is argenx SE Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


argenx SE Cyclically Adjusted PB Ratio Historical Data

The historical data trend for argenx SE's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

argenx SE Cyclically Adjusted PB Ratio Chart

argenx SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 18.98 14.63

argenx SE Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16.55 - 14.63 -

Competitive Comparison of argenx SE's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, argenx SE's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


argenx SE's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, argenx SE's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where argenx SE's Cyclically Adjusted PB Ratio falls into.



argenx SE Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

argenx SE's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, argenx SE's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/128.5800*128.5800
=0.000

Current CPI (Mar. 2024) = 128.5800.

argenx SE Quarterly Data

Book Value per Share CPI Adj_Book
201312 1.393 98.360 1.821
201403 1.258 99.390 1.627
201406 1.119 99.240 1.450
201409 0.000 99.960 0.000
201412 3.145 99.050 4.083
201503 0.000 99.750 0.000
201506 2.812 100.230 3.607
201509 0.000 100.500 0.000
201512 2.368 99.730 3.053
201603 0.000 100.310 0.000
201606 3.724 100.260 4.776
201609 0.000 100.570 0.000
201612 3.139 100.710 4.008
201703 0.000 101.440 0.000
201706 5.693 101.370 7.221
201709 0.000 102.030 0.000
201712 10.866 101.970 13.702
201803 0.000 102.470 0.000
201806 10.155 103.100 12.665
201809 0.000 103.950 0.000
201812 15.048 103.970 18.610
201903 0.000 105.370 0.000
201906 17.570 105.840 21.345
201909 0.000 106.700 0.000
201912 24.844 106.800 29.911
202006 34.269 107.510 40.985
202012 28.926 107.850 34.486
202103 0.000 108.870 0.000
202106 47.669 109.670 55.888
202109 0.000 110.790 0.000
202112 43.407 114.010 48.954
202203 0.000 119.460 0.000
202206 51.032 119.050 55.117
202209 0.000 126.890 0.000
202212 47.948 124.940 49.345
202303 0.000 124.720 0.000
202306 47.144 125.830 48.174
202309 0.000 127.160 0.000
202312 63.476 126.450 64.545
202403 0.000 128.580 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


argenx SE  (FRA:1AE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


argenx SE Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of argenx SE's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


argenx SE (FRA:1AE) Business Description

Industry
Address
Laarderhoogtweg 25, Amsterdam, NH, NLD, 1101EB
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.

argenx SE (FRA:1AE) Headlines

No Headlines